Oneview Healthcare (ASX:ONE) - CEO, James Fitter (left) and President & Founder, Mark McCloskey (right)
CEO, James Fitter (left) and President & Founder, Mark McCloskey (right)
Source: Silicon Republic
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Oneview Healthcare (ONE) has launched the world’s first cloud-based care experience platform, CXP Cloud Enterprise
  • The platform offers cloud deployment with features for both patients and care providers, like meal ordering, video chat, patient education and translation services
  • The company says this comes at a critical time to meet the demand for digital health services being driven by the pandemic
  • Following the news, Oneview shares jumped 24.14 per cent to trade for 36 cents each

Oneview Healthcare (ONE) has launched the world’s first cloud-based care experience platform, CXP Cloud Enterprise.

The platform, deployed on Microsoft Azure, enables health systems to quickly adopt technology for engaging patients, reducing non-clinical demands on care teams and optimising clinical and operational effectiveness.

CXP Cloud Enterprise offers a secure, reliable cloud deployment with patient education, meal ordering, service requests, apps and digital services, visitation, entertainment, video chat and translation services — all aiming to drive better control and quality care for both patients and care providers.

The platform was developed in partnership with NYU Langone Health, an academic medical centre in New York, which rapidly rolled out the virtual engagement platform across its facilities during the COVID-19 pandemic to address the increased pressure on care teams and patient’s restricted access to family and friends.

NYU Langone and Oneview collaborated on the initial cloud-based version that enabled the implementation of key capabilities across 400 beds in just weeks. According to the company, today’s launch now offers full function and integration of care capabilities in a faster, easier, more affordable cloud model at the bedside.

“Being the first and only cloud-based care experience solution gives us a strong competitive advantage and means health systems can rapidly implement the capabilities that meet their needs today while providing the agility, scalability and investment protection to grow as their health system changes,” said Chief Executive Officer James Fitter.

“We are excited to know that CXP Cloud Enterprise will help transform the hospital experience for patients, families and care teams.”

Dr Simon Kos, Healthcare Industry Executive at Microsoft Australia ,described the new platform as a game changer for the medical industry.

“It means that health organisations can deploy more quickly, with greater predictability and less specialised resources, all on the trusted Azure cloud. This is a win for patients, clinicians and healthcare organisations that put patient experience and outcomes first,” said Kos.  

The company says this comes at a critical time to meet the rising demand for digital health services being driven by the pandemic.

Oneview also released its annual report today, detailing at $9.1 million loss in 2021. This represents an improvement on a loss of nearly $17 million in the previous year.

Revenue for the year remained stable however, at just over $7 million.

Following the news, Oneview shares jumped 24.14 per cent to trade for 36 cents each at 10:31 am AEDT.

ONE by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…